Oct 29, 2026 08:00AM
Sep 1, 2026 09:07AM
Dec 21, 2025 04:00AM
Apr 10, 2025 05:32AM
Mar 21, 2025 07:44AM
Mar 21, 2025 06:47AM
Feb 26, 2025 09:35AM RBC on Alnylam Pharmaceuticals (ALNY): 'We Would Be Buyers Ahead Of Upcoming PDUFA Date'
Feb 26, 2025 08:10AM
Feb 25, 2025 07:00AM
Feb 25, 2025 06:45AM
Feb 13, 2025 08:00AM
Jan 14, 2025 06:44AM
Jan 13, 2025 12:21PM
Jan 13, 2025 11:20AM Alnylam Pharma (ALNY) Announces Preliminary Fourth Quarter and Full Year 2024 Global Net Product Revenues and Provides 2025 Combined Net Product Revenue Guidance
Jan 12, 2025 04:00PM
Nov 25, 2024 08:23AM
Nov 25, 2024 07:01AM
Nov 25, 2024 07:00AM
Oct 10, 2024 08:21AM
Feb 16, 2024 07:46AM
Oct 6, 2023 07:00AM Alnylam to Present Additional Data for Patisiran in Patients With the Cardiomyopathy of ATTR Amyloidosis, Including 24-Month Results From the APOLLO-B Phase 3 Study, at the Heart Failure Society of Am
Sep 13, 2023 04:57PM
Sep 13, 2023 04:57PM
Sep 13, 2023 07:01AM
Sep 13, 2023 07:00AM
Aug 3, 2023 08:00AM
Jun 30, 2023 09:00AM
Jun 30, 2023 09:00AM Alnylam Announces Date of Planned FDA Advisory Committee Meeting for ONPATTRO® (patisiran) for the Treatment of the Cardiomyopathy of ATTR Amyloidosis
May 22, 2023 05:46AM
May 20, 2023 10:50AM
May 4, 2023 08:00AM
Feb 23, 2023 08:00AM
Feb 21, 2023 08:01AM
Feb 21, 2023 08:00AM
Jun 15, 2022 09:09AM Alnylam Pharmaceuticals' (ALNY) Subcutaneous Amvuttra ATTR-PN Approval Is a Key Step for Growth Expansion Plan - Jefferies
May 23, 2022 07:01AM
May 23, 2022 07:00AM
Apr 28, 2022 08:00AM
Apr 4, 2022 04:17PM
Apr 4, 2022 11:46AM
Apr 4, 2022 08:15AM
Apr 4, 2022 07:34AM Alnylam Pharma (ALNY) Announces 3-Month Extension of Review Period for New Drug Application for Vutrisiran
Apr 4, 2022 07:30AM
Mar 1, 2022 07:01AM
Mar 1, 2022 07:00AM
Feb 17, 2022 09:18AM
Feb 11, 2022 07:21AM
Feb 11, 2022 05:13AM
Jan 21, 2022 07:30AM Alnylam Pharma (ALNY) Reports Positive 18-Month Results from HELIOS-A Phase 3 Study
Jan 21, 2022 07:30AM

16,037 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All